Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 13

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease

Total article views   HTML views PDF downloads Totals
4,703 Dovepress* 4,266+ 850 5,116
PubMed Central* 437 139 576
Totals 4,703 989 5,692
*Since 6 October 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar